[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343109-105":59,"doc-detail-343109-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","machine-learning-enables-pan-cancer-identification-of-mutational-hotspots-at-persistent-ctcf-binding-sites","Machine learning enables pan-cancer identification of mutational hotspots at persistent CTCF binding sites","","CCCTC-binding factor (CTCF) is an insulator protein that binds a conserved DNA motif and shapes 3D nuclear architecture and transcription. CTCF binding sites in non-coding DNA are frequently mutated in cancer, including a subclass called persistent CTCF binding sites (P-CTCF-BSs) that resist CTCF knockdown. Using ICGC sequencing, P-CTCF-BSs show elevated mutation rates and mutational burden across 12 cancer types. A machine-learning tool, CTCF-INSITE, predicts persistence from genetic and epigenetic features and identifies mutations with functional impact, with in vitro assays confirming reduced CTCF binding.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/machine-learning-enables-pan-cancer-identification-of-mutational-hotspots-at-persistent-ctcf-binding-sites/343109/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/machine-learning-enables-pan-cancer-identification-of-mutational-hotspots-at-persistent-ctcf-binding-sites/343109.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are persistent CTCF binding sites (P-CTCF-BSs)?","Question",{"text":112,"@type":113},"P-CTCF-BSs are a subclass of CTCF binding sites that remain bound despite CTCF knockdown, showing high binding conservation and distinct genetic and epigenetic properties.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the pan-cancer enrichment of P-CTCF-BS mutations assessed?",{"text":117,"@type":113},"The study used ICGC sequencing data to compare mutation rates of P-CTCF-BSs against all CTCF binding sites and found elevated mutation rates in multiple cancer types.",{"name":119,"@type":110,"acceptedAnswer":120},"What is CTCF-INSITE and what does it predict?",{"text":121,"@type":113},"CTCF-INSITE is a machine-learning tool that predicts the persistence of CTCF binding sites from genetic and epigenetic features of experimentally determined P-CTCF-BSs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343109,1790693272,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Nucleic Acids Research, 2024, 52, 8086–8099 [https://doi.org/10.1093/nar/gkae530](https://doi.org/10.1093/nar/gkae530)  \nAdvance access publication date: 2 July 2024  \nComputational Biology  \nMachine learning enables pan-cancer identification of mutational hotspots at persistent CTCF binding sites  \nWenhan Chen 1 , Yi C. Zeng 2 ,3 , Joanna Achinger-Kawecka 1 ,3 , Elyssa Campbell 1 ,  \nAlicia K. Jones 1 , Alastair G. Stewart 2 ,3 , Amanda Khoury 1 ,3 , * and Susan J. Clark 1 ,3 , *  \n1 Epigenetics Laboratory, Garvan Institute of Medical Research, Sydney 2010 New South Wales, Australia  \n2 Structural Biology Laboratory, Victor Chang Cardiac Research Institute, Sydney 2010 New South Wales, Australia  \n3 St Vincent’s Clinical School, UNSW, Sydney 2010 New South Wales, Australia  \n* To whom correspondence should be addressed. Email: [a.khoury@garvan.org.au](a.khoury@garvan.org.au)[ ](a.khoury@garvan.org.au)Correspondence may also be addressed to Susan J. Clark. Email: [s.clark@garvan.org.au](s.clark@garvan.org.au)  \nPresent address: Wenhan Chen, Computational Biology Group, Children’s Cancer Institute, Sydney 2031 New South Wales, Australia.  \nAbstract  \nCCCTC-binding factor (CTCF) is an insulator protein that binds to a highly conserved DNA motif and facilitates regulation of three-dimensional (3D) nuclear architecture and transcription. CTCF binding sites (CTCF-BSs) reside in non-coding DNA and are frequently mutated in cancer. Our previous study identified a small subclass of CTCF-BSs that are resistant to CTCF knock down, termed persistent CTCF binding sites (P-CTCFBSs) . P-CTCF-BSs show high binding conservation and potentially regulate cell-type constitutive 3D chromatin architecture. Here, using ICGC sequencing data we made the striking observation that P-CTCF-BSs display a highly elevated mutation rate in breast and prostate cancer when compared to all CTCF-BSs. To address whether P-CTCF-BS mutations are also enriched in other cell-types, we developed CTCF-INSITE—a tool utilising machine learning to predict persistence based on genetic and epigenetic features of experimentally-determined P-CTCF-BSs. Notably, predicted P-CTCF-BSs also show a significantly elevated mutational burden in all 12 cancer-types tested. Enrichment was even stronger for P-CTCF-BS mutations with predicted functional impact to CTCF binding and chromatin looping. Using in vitro binding assays we validated that P-CTCF-BS cancer mutations, predicted to be disruptive, indeed reduced CTCF binding. Together this study reveals a new subclass of cancer specific CTCF-BS DNA mutations and provides insights into their importance in genome organization in a pan-cancer setting.  \nGraphical abstract  \nIntroduction  \nThe CCCTC-binding factor (CTCF) is an 11-zinc finger DNAbinding protein ubiquitously expressed in eukaryotes. CTCF  \nrecognizes a consensus DNA sequence motif (1,2) and binds to tens of thousands of open chromatin sites across the human genome in a cell-type specific manner (3) . There is  \nReceived: September 29, 2023. Revised: May 15, 2024. Editorial Decision: May 19, 2024. Accepted: June 13, 2024  \n© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https:](https://creativecommons.org/licenses/by-nc/4.0/)[//](https://creativecommons.org/licenses/by-nc/4.0/)[creativecommons.org](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[licenses](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[by-nc](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)[4.0](https://creativecommons.org/licenses/by-nc/4.0/)[/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided","cbCaidhgwkWfipwp","https://ap.wps.com/l/cbCaidhgwkWfipwp","pdf",1901936,14,"English","# Abstract\n# Introduction\n## CTCF and CTCF binding sites\n## Persistent vs lost CTCF binding sites","[{\"question\":\"What are persistent CTCF binding sites (P-CTCF-BSs)?\",\"answer\":\"P-CTCF-BSs are a subclass of CTCF binding sites that remain bound despite CTCF knockdown, showing high binding conservation and distinct genetic and epigenetic properties.\"},{\"question\":\"How was the pan-cancer enrichment of P-CTCF-BS mutations assessed?\",\"answer\":\"The study used ICGC sequencing data to compare mutation rates of P-CTCF-BSs against all CTCF binding sites and found elevated mutation rates in multiple cancer types.\"},{\"question\":\"What is CTCF-INSITE and what does it predict?\",\"answer\":\"CTCF-INSITE is a machine-learning tool that predicts the persistence of CTCF binding sites from genetic and epigenetic features of experimentally determined P-CTCF-BSs.\"}]","Machine learning enables pan-cancer identification of mutational hotspots at persistent CTCF binding sites | PDF",1790049936,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abfdde52f6d4cd6f693a07a4108fc0d2.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fd73b80e8f020e9a57e01c21e15f6b6.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eaf2a5bee20bea15281e15aa8bdd77f.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4d830026a85d3f0af3c1f1c46321e09.webp",980,1268]